The energy at DMEA in Berlin highlighted the growing demand for innovative healthcare technologies that improve infection prevention, support clinical workflows, and enhance operational efficiency.
For Seal Shield and INOVIS Medical, this year’s event represented more than a successful exhibition—it marked a significant milestone in a strategic partnership focused on expanding access to Seal Shield’s healthcare solutions across Europe through the launch of Seal Shield EU.
A Partnership Built for European Growth
One of the most exciting developments showcased at DMEA was the continued collaboration between Seal Shield and INOVIS Medical to establish a stronger European presence and deliver enhanced service to healthcare organizations throughout the region.
As healthcare providers increasingly seek reliable, infection-control-focused technology solutions, both companies recognize the importance of having a localized infrastructure that can support customers efficiently and effectively. Through this partnership, Seal Shield and INOVIS Medical are building a foundation that combines industry-leading healthcare technology with regional expertise, distribution capabilities, and customer support.
The launch of Seal Shield EU represents a major step toward creating a streamlined European supply chain that enables healthcare organizations to access products faster, reduce procurement complexity, and benefit from improved product availability.
Strengthening Distribution and Logistics Across Europe
A key objective of the partnership is the development of a robust European distribution network designed to support growing demand throughout the continent.
By leveraging INOVIS Medical’s established healthcare network and operational expertise, Seal Shield EU is positioned to provide:
- Faster delivery times across European markets
- Improved inventory availability and forecasting
- Reduced lead times for healthcare facilities and channel partners
- More efficient logistics and fulfillment operations
- Enhanced technical and customer support within the region
- Greater responsiveness to the needs of European healthcare providers
This localized approach helps ensure that hospitals, clinics, and healthcare systems can access critical infection prevention technologies without the delays and complexities often associated with transatlantic supply chains.
The collaboration also creates opportunities to work more closely with healthcare organizations on implementation, training, and long-term support, helping customers maximize the value of their technology investments.
Strong Interest in Hygienic Input Solutions
Throughout the conference, visitors experienced firsthand how Seal Shield’s hygienic technologies help healthcare organizations reduce contamination risks while maintaining productivity and ease of use.
Among the most talked-about products at the booth were the Seal Silk Pro and Cleanwipe Pro keyboards, which attracted significant interest from healthcare IT leaders, infection prevention specialists, and clinical engineering teams.
The response was particularly strong when the keyboards were demonstrated alongside medical cart solutions and complete workflow solutions. Attendees recognized the value of combining mobile clinical workstations with fully washable and disinfectable input devices, creating cleaner and more efficient point-of-care environments.
Key benefits highlighted during demonstrations included:
- Improved infection prevention practices
- Seamless mobility for clinical workflows
- Durable healthcare-grade construction
- Ease of cleaning and disinfection
- Familiar user experience for clinical staff
The integration of hygienic peripherals with mobile workstation platforms generated valuable discussions around creating safer and more efficient care environments throughout healthcare facilities.
Hands-On Experience with UV-C Disinfection Technology
Another major attraction at the booth was the opportunity to experience Seal Shield’s UV-C disinfection systems in action.
Visitors engaged with the ElectroClave and CleanSlate sanitization solutions throughout the event, exploring how automated UV-C disinfection can support infection prevention initiatives and simplify sanitization workflows.
Healthcare professionals showed strong interest in technologies that can help:
- Standardize disinfection processes
- Improve compliance with cleaning protocols
- Reduce device turnaround times
- Support broader infection prevention strategies
- Enhance operational efficiency in high-touch environments
The live demonstrations allowed attendees to see how UV-C technology can be seamlessly incorporated into daily healthcare operations.
Looking Ahead
DMEA 2026 demonstrated not only the growing demand for innovative infection prevention solutions but also the value of strategic partnerships that bring those solutions closer to healthcare providers.
As Seal Shield and INOVIS Medical continue to strengthen their collaboration, both organizations remain committed to building a highly responsive European infrastructure that supports customers with reliable distribution, optimized logistics, localized expertise, and industry-leading hygienic technology solutions.
Together, Seal Shield and INOVIS Medical look forward to expanding their presence throughout the region and helping healthcare organizations advance infection prevention and clinical workflow excellence for years to come.
